NCT05219084View on ClinicalTrials.gov

Hip Denervation and Intra-articular Hydration in Damaged Hip in Axial Spondyloarthritis Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

April 15, 2022

Study Completion Date

April 15, 2022

Conditions
Patients With Axial SpA According to ASAS CriteriaPatients With Unilateral or Bilater Hip Damage According to BASRI ScoreAge > 18
Interventions
DRUG

hip denervation

Lidocaine 2% 2ml was injected into each genicular nerve

DRUG

intra-articular hydration

10 ml; of normal; saline were injected inside the hip joint

DRUG

Combined group

hip denervation and intra-articular hydration were conducted together

DRUG

Control group

Normal; saline was injected subcutaneously

Trial Locations (1)

82749

Ahmed Elsaman, Sohag

All Listed Sponsors
collaborator

Suez Canal University

OTHER

lead

Sohag University

OTHER

NCT05219084 - Hip Denervation and Intra-articular Hydration in Damaged Hip in Axial Spondyloarthritis Patients | Biotech Hunter | Biotech Hunter